title: [Treatment of pemphigus with rituximab].
abstract: Pemphigus is a life-threatening autoimmune blistering disease affecting the skin and mucosa. Patients with severe pemphigus require long-term treatment with corticosteroids and other immunosuppressive drugs, which can lead to serious adverse events. Rituximab, a monoclonal antibody directed against the CD20 antigen of B lymphocytes, has been demonstrated to be effective in recalcitrant and life-threatening pemphigus.
authors.affiliation: Department of Dermatology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. lijun35@hotmail.com
authors.forename: Jun
authors.initials: J
authors.lastname: Li
authors.forename: He-Yi
authors.initials: HY
authors.lastname: Zheng
authors.forename: Yue-Hua
authors.initials: YH
authors.lastname: Liu